CommentWill anti-amyloid therapies work for Alzheimer's disease?
References (13)
- et al.
Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
Lancet
(2008) - et al.
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Biochem Biophys Res Commun
(1984) - et al.
Aβ−42 deposition precedes other changes in PS-1 Alzheimer's disease
Lancet
(1998) - et al.
Immunization with Aβ attenuates Alzheimer's Disease-like pathology in the PDAPP mouse
Nature
(1999) - et al.
Aβ immunization reduces behavioural impairment and dense-cored plaques in a model of Alzheimer's disease
Nature
(2000) - et al.
Aβ oligomers—a decade of discovery
J Neurochem
(2007)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2008 Elsevier Ltd. All rights reserved.